SPR Therapeutics has developed a novel, minimally-invasive peripheral nerve stimulation (PNS) therapy platform that addresses a critical unmet need for chronic and post-operative/acute pain
Alleviating the need for opioids and surgery, the SPRINT™ PNS System is the least-invasive and lowest-cost neurostimulation option that allows the large base of interventional pain management physicians to adopt this non-destructive therapy early in the treatment continuum
Value Provided by Frontcourt
Engaged and acted as Financial Advisor
Created and implemented Corporate Public Relations strategy
Engaged and introduced leading pain management Key Industry thought leaders
Engaged and introduced key potential customer contacts
Frontcourt identified and structured an oversubscribed Series C offering
Participation from Frontcourt Ventures, Frontcourt individual LP’s and several independent value-added institutional investors
Identified and introduced value-added Industry executives and Board Members
